Vivos Therapeutics Inc (VVOS) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.16 (-6.36%), Market cap $0.01B, 52-week low–high $0.58 ~ $6.95.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was
Financial statements, price targets, institutional (13F) holdings and related news for Vivos Therapeutics Inc are updated in real time on BlackAll Trade.
Vivos Therapeutics Inc trades at $0.16 (-6.36%). Real-time quotes and charts are available on BlackAll Trade.
Vivos Therapeutics Inc has a market cap of about $0.01B.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive